InMode Ltd.(INMD)

Sector:

Healthcare

Description:

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

Current Price

$33.50

RSI

63.97

Market Capitalization:

3.1B

Beta:

1.983

Volume:

1,012,988

Analyst Target Price:

$ 81.5

Economiic Fair Price:


February 09, 2023
June 30, 2022
Q2
N/A
N/A
N/A
N/A
N/A
88.4M
3.7M
1.92
46.10 %
4.39
0.492

41.47 %
45.41 %
30.50 %
30.03 %
15.06 %
0.01 %

$ 357.6M
73.49 %
$ 206.1M
31.81 %
$ 156.4M
56.11 %
$ 100.2M
87.37 %
$ 53.5M

$ 173.9M
120.85 %
$ 78.8M
28.04 %
$ 61.5M
68.51 %
$ 36.5M
153.16 %
$ 14.4M

$ 168M
120.67 %
$ 76.1M
22.71 %
$ 62M
162.61 %
$ 23.6M
141.10 %
$ 9.8M

News

Press Releases

Notable Dates